E. Mathias

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients

Julie Jézéquel, Emily M. Johansson, Julien P. Dupuis et al. · Nature Communications · 2017 · 142 citations · Full text

Life Sciences, Neuroscience, Psychiatry +17

Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis

Evgenia Karantoni, Aurélien Viaccoz, François Ducray et al. · Journal of Neurology · 2015 · 120 citations

Medicine, Neurology, Pediatrics +11

Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)

Cristina Saura, Shanu Modi, Ian E. Krop et al. · Annals of Oncology · 2023 · 108 citations · Full text

Medicine, Oncology, Pharmacology +16

377O A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB) -01, -02, and -03

S.A. Hurvitz, Shanu Modi, Wěi Li et al. · Annals of Oncology · 2023 · 58 citations · Full text

Medicine, Oncology, Breast Oncology +15